These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ligand-induced downregulation of receptor-mediated clearance of hepatocyte growth factor in rats. Liu KX, Kato Y, Kino I, Nakamura T, Sugiyama Y. Am J Physiol; 1998 Nov; 275(5):E835-42. PubMed ID: 9815004 [Abstract] [Full Text] [Related]
7. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Zioncheck TF, Richardson L, DeGuzman GG, Modi NB, Hansen SE, Godowski PJ. Endocrinology; 1994 Apr; 134(4):1879-87. PubMed ID: 8137756 [Abstract] [Full Text] [Related]
8. Contribution of parenchymal and non-parenchymal liver cells to the clearance of hepatocyte growth factor from the circulation in rats. Liu KX, Kato Y, Terasaki T, Aoki S, Okumura K, Nakamura T, Sugiyama Y. Pharm Res; 1995 Nov; 12(11):1737-40. PubMed ID: 8592679 [Abstract] [Full Text] [Related]
15. Expression of hepatocyte growth factor in normal and carbon tetrachloride-treated monkeys. Kawakami S, Tsubouchi H, Nakagawa S, Hirono S, Arakaki N, Nakamura O, Daikuhara Y, Arima T. Hepatology; 1994 Nov; 20(5):1255-60. PubMed ID: 7927260 [Abstract] [Full Text] [Related]
16. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats. Iwamoto K, Watanabe J, Araki K, Satoh M, Deguchi N. J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680 [Abstract] [Full Text] [Related]
17. Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats. Liu KX, Kato Y, Kato M, Kaku TI, Nakamura T, Sugiyama Y. Am J Physiol; 1997 Nov; 273(5):E891-7. PubMed ID: 9374673 [Abstract] [Full Text] [Related]